AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy products that treat cancer-related lymphedema and venous complications, today announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments following multiple regulatory approvals.
January 13, 2020 Government Industry Press Room Regulatory
AIROS Medical Granted FDA 510k Clearance to Market Compression Device for Lymphedema Treatment
Audubon, PA – January 13, 2020 – AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema and venous complications, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.
August 21, 2018 Industry Press Room Regulatory
AIROS Medical Assigned HCPCS Codes from PDAC for AIROS 6 and AIROS 8 Devices
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced that the Pricing, Data, Analysis, and Coding (PDAC) contractor for Center for Medicare & Medicaid Services (CMS) has approved Healthcare Common Procedure Coding System (HCPCS) codes for the AIROS 6 and AIROS 8 devices and their respective accessories.
June 22, 2018 Industry Press Room Regulatory
AIROS Medical Receives Two FDA 510(k) Clearances for Sequential Compression Devices
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced it has received two 510(k) regulatory clearances to market medical devices from the U.S. Food and Drug Administration (FDA).